We have observed
13 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
January 19, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ARYL DERIVATIVES FOR CONTROLLING ECTOPARASITES
SYSTEM FOR PROVIDING A LIQUID-SUBSTANCE MIXTURE ATTRACTIVE TO AN ANIMAL
TREATMENT OF FISH POPULATIONS WITH LUFENURON
NEW TREATMENT OF FISH WITH A NANOSUS PENS ION OF LUFENURON OR HEXAFLUMURON
SUBTITUTED AZINES AS PESTICIDES
Aminosulfonylmethylcyclohexanes as JAK inhibitors
AN ORAL IRON (III) BASED PHOSPHATE ADSORBENT FOR TREATING IRON-DEFICIENCY ANEMIA IN CATS WITH CHRONIC KIDNEY DISEASE
(HETERO) ARYLACRYLAMIDES FOR THE CONTROL OF ECTOPARASITES
ANTHRANILAMIDES, SULFONAMIDES AND NITRO ANALOGUES DERIVED THEREFROM AS ANTHELMINTICS
ISOXAZOLINE DERIVATIVES FOR CONTROLLING INVERTEBRATE PESTS